Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -3.04% | 151.00 | 0.0% | $2687.89m | |
| BNGO | BioNano Genomics, Inc. | -4.80% | 10.51 | 0.0% | $2167.61m | |
| GILD | Gilead Sciences, Inc. | -0.73% | 65.00 | 1.0% | $644.16m | |
| AMGN | Amgen, Inc. | 0.05% | 251.19 | 1.3% | $589.76m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.51% | 523.36 | 2.7% | $497.84m | |
| ILMN | Illumina, Inc. | -0.42% | 430.26 | 3.5% | $490.22m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.42% | 155.03 | 2.0% | $464.00m | |
| CRSP | CRISPR Therapeutics AG | 0.00% | 163.95 | 0.6% | $436.82m | |
| NVAX | Novavax, Inc. | -3.19% | 127.00 | 92.9% | $401.44m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.70% | 223.67 | 1.9% | $375.62m | |
| SRPT | Sarepta Therapeutics, Inc. | -4.52% | 86.40 | 13.8% | $325.41m | |
| BIIB | Biogen, Inc. | -0.13% | 264.80 | 1.7% | $313.92m | |
| SRNE | Sorrento Therapeutics, Inc. | -6.44% | 14.25 | 1.4% | $313.10m | |
| BNTX | BioNTech SE | -0.21% | 105.75 | 0.0% | $292.92m | |
| EXAS | EXACT Sciences Corp. | 0.00% | 136.85 | 19.6% | $253.85m |
Company Profile
Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development and commercialization of novel vaccines and immuno-oncology therapeutics. The firm focuses on leveraging the body's innate and adaptive immune responses through toll-like receptor stimulation. It offers products for vaccines, cancer immunotherapy, and immune-mediated diseases. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Berkeley, CA.